In angiogenesis, the process in which blood vessel sprouts grow out from a pre‐existing vascular network, the so‐called endothelial tip cells play an essential role. Tip cells are the leading cells of the sprouts; they guide following endothelial cells and sense their environment for guidance cues. Because of this essential role, the tip cells are a potential therapeutic target for anti‐angiogenic therapies, which need to be developed for diseases such as cancer and major eye diseases. The potential of anti‐tip cell therapies is now widely recognised, and the surge in research this has caused has led to improved insights in the function and regulation of tip cells, as well as the development of novel
in vitro
and
in silico
models. These new models in particular will help understand essential mechanisms in tip cell biology and may eventually lead to new or improved therapies to prevent blindness or cancer spread.
Key Concepts
Sprouting angiogenesis is led by tip cells, which can sense their environment and direct the sprouting process.
Tip cells are followed by stalk cells, which have a more proliferative phenotype.
The number of tip cells is regulated by lateral inhibition between the tip cells and the stalk cells; the tip cells prevent the adjacent cells from becoming tip cells and thereby optimise the number of tip cells.
The tip cell and stalk cell phenotype are definite, and stalk cells can overtake tip cells through stochastic cellular and environmental differences, the stalk cells then become tip cells and force the former tip cells to become stalk cells.
Tip cells exist in human umbilical vein endothelial cell cultures and can therefore be studied
in vitro
.